Home › Funds › BVF INC/IL › GLUE

BVF INC/IL position in GLUE

MONTE ROSA THERAPEUTICS INC · Health Care

BVF INC/IL reported holding 4,460,886 shares of GLUE (MONTE ROSA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$108.0M, representing 2.76% of its reported portfolio and ranking #11 among its reported holdings. BVF INC/IL has disclosed GLUE holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)4.46M sh
Reported value held$107.95M
Portfolio Weight2.76%
First reportedQ4 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BVF INC/IL's GLUE position evolved

BVF INC/IL first disclosed a stake in GLUE in Q4 2024 at 2,764,471 shares (US$19.2M). The position peaked in Q2 2026 at 4,460,886 shares, worth US$108.0M. Across 7 filings, BVF INC/IL increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 4,460,886 shares valued at US$108.0M. Notable position changes include a 105% increase in Q1 2025 (shares fell 3% over the following quarter), a 32% trim in Q4 2025 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 2.76M $19.19M New
Q1 2025 5.66M $26.26M Add
Q2 2025 5.66M $25.53M Hold
Q3 2025 5.66M $41.94M Hold
Q4 2025 3.84M $60.15M Reduce
Q1 2026 4.46M $73.38M Add
Q2 2026 4.46M $107.95M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GLUE and 13F data

GLUE (MONTE ROSA THERAPEUTICS INC) is a Health Care company. 73 other funds we track also report a position in GLUE — the largest reported positions include NEA Management Company, LLC (US$186.2M), TCG Crossover Management, LLC (US$111.9M), Vestal Point Capital, LP (US$111.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GLUE

All GLUE fund holders →

FAQ

How long has BVF INC/IL held GLUE?

BVF INC/IL has disclosed GLUE holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is BVF INC/IL's current position in GLUE?

As of Q2 2026, BVF INC/IL holds 4.46M shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $107.95M, representing 2.76% of its reported portfolio and ranking #11.

Has BVF INC/IL been buying or selling GLUE?

In the latest 13F filing (Q2 2026), BVF INC/IL held unchanged its position in GLUE. The position peaked in Q2 2026 at 4.46M shares.

Which other funds hold GLUE?

Other major institutional holders of GLUE include NEA Management Company, LLC, TCG Crossover Management, LLC, Vestal Point Capital, LP, among 73 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.